FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2603011000001103: Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2311551000001117 Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2311561000001119 Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Is a Betahistine 8mg tablets 120 tablet true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Is pack of Betahistine 8mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has active ingredient Betahistine dihydrochloride false Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has active ingredient Betahistine false Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has AMP Betahistine 8mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has specific active ingredient Betahistine dihydrochloride true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Betahistine 8mg tablets (Kent Pharma (UK) Ltd) 120 tablet 10 x 12 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start